2024-515074-26-00
Not yet recruiting
Phase 1
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- AgomAb Therapeutics
- Enrollment
- 64
- Locations
- 1
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Clinical Operations
Scientific
AgomAb Therapeutics
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of a novel test product for treatment of epidermal melasmaHealth Condition 1: L814- Other melanin hyperpigmentationCTRI/2023/12/060478SHNI Ventures LLP
Completed
Not Applicable
Safety and tolerability of a vaginal ointment without any active drugs in healthy women.ACTRN12617000778381Zenith Technology Corporation Limited9
Recruiting
Phase 1
Investigating the endolift method in the treatment of primary axillary hyperhidrosisIRCT20200127046282N43Tehran University of Medical Sciences10
Active, not recruiting
Not Applicable
Evaluation of efficacy, safety and tolerability of an ADd-on therapy with Cianocabalamine Vitamin B12 plus Calcium levofolinate in relapsing-remitting multiple sclerosis patients Already in treatment with Nterferon beta over a period of 24 months for a better lonterm outComE - ADVANCEEUCTR2005-006071-12-ITAZIENDA OSPEDALIERA SAN CAMILLO FORLANINI276
Not yet recruiting
Not Applicable
Soft capsules with ozonated sunflower oil versus oral OLEOZON® in patients with GiardiosisGiardiosisRPCEC00000440ational Centre for Scientific Research (CNIC)200